Beximco Pharmaceuticals (BXP) Stock Chart & Stock Price History GBX 38.50 0.00 (0.00%) As of 02/21/2025 Add Compare Share Share Chart Stock AnalysisChartCompetitorsHeadlines Beximco Pharmaceuticals Stock Price Performance 5 Day Performance-2.04%1 Month Performance-1.22%3 Month Performance+14.93%6 Month Performance+32.87%Year-To-Date Performance+0.79%1 Year Performance-4.94% Receive BXP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Beximco Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address BXP Stock Chart for Saturday, February, 22, 2025 BXP Chart by TradingView Beximco Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization02/21/2025GBX 38GBX 38GBX 38.50GBX 3835,400 shs£25.90 billion02/20/2025GBX 39.70GBX 38-4.28%GBX 38.50GBX 3835,400 shs£25.90 billion02/19/2025GBX 37.61GBX 39.70+5.55%GBX 39.70GBX 38.5025,000 shs£27.06 billion02/18/2025GBX 39.30GBX 37.61-4.30%GBX 39.20GBX 37.5510,893 shs£25.64 billion02/17/2025GBX 39.30GBX 39.30GBX 39.38GBX 39.301,000 shs£26.79 billion02/14/2025GBX 38.63GBX 39.30+1.73%GBX 39.38GBX 39.301,000 shs£26.79 billion02/13/2025GBX 39.67GBX 38.63-2.62%GBX 39.55GBX 38.6352,000 shs£26.33 billion02/12/2025GBX 38.40GBX 39.67+3.31%GBX 39.67GBX 37107,735 shs£176.97 million02/11/2025GBX 38.45GBX 38.40-0.13%GBX 38.50GBX 38.4070,935 shs£171.31 million02/10/2025GBX 38.45GBX 38.45GBX 38.45GBX 37.427,000 shs£171.53 million Get the Latest News and Ratings for BXP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Beximco Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 02/07/2025GBX 38.20GBX 38.45+0.65%GBX 38.50GBX 38.455,050 shs£171.53 million02/06/2025GBX 38.20GBX 38.20GBX 38.20GBX 37.4054,081 shs£170.41 million02/05/2025GBX 38GBX 38.20+0.53%GBX 38.20GBX 37.4054,081 shs£170.41 million02/04/2025GBX 38GBX 38GBX 38GBX 37.38238,683 shs£169.52 million02/03/2025GBX 38GBX 38GBX 38GBX 37.38238,683 shs£169.52 million01/31/2025GBX 37GBX 38+2.70%GBX 38.50GBX 3871,741 shs£169.52 million01/30/2025GBX 37.25GBX 37-0.67%GBX 40GBX 37120,323 shs£165.06 million01/29/2025GBX 38.60GBX 37.25-3.50%GBX 38.70GBX 37.252.09 million shs£166.18 million01/28/2025GBX 37.33GBX 38.60+3.39%GBX 38.60GBX 38.504,217 shs£172.20 million01/27/2025GBX 37.27GBX 37.33+0.18%GBX 38.90GBX 37.333,319 shs£166.55 million01/24/2025GBX 38.98GBX 37.27-4.38%GBX 38.50GBX 37.274,000 shs£166.25 million01/23/2025GBX 38.98GBX 38.98GBX 38.98GBX 38.5022,501 shs£173.87 million01/22/2025GBX 38.98GBX 38.98GBX 38.98GBX 38.5022,501 shs£173.87 million01/21/2025GBX 37.17GBX 38.98+4.87%GBX 38.98GBX 38.5022,501 shs£173.87 million Related Companies Prs Reit Stock Chart Molten Ventures Stock Chart Pinewood Technologies Group Stock Chart Triple Point Social Housing REIT Stock Chart AdvancedAdvT Stock Chart Saga Stock Chart Aurora Investment Trust Stock Chart Celtic Stock Chart Corero Network Security Stock Chart Value and Indexed Property Income Stock Chart Receive BXP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Beximco Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (LON:BXP) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | SponsoredHow to trade Executive Order 14154Trump’s pen must be running out of ink… Since he returned to office he’s signed more than 50 Executive Orde...Porter & Company | SponsoredMajor AI announcement for 2025BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI StocksBrownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Beximco Pharmaceuticals Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Beximco Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
